Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Feb;49(2):207–213. doi: 10.1038/bjc.1984.33

The effect of phenytoin, phenobarbitone, dexamethasone and flurbiprofen on misonidazole neurotoxicity in mice.

P W Sheldon, C Clarke, K B Dawson
PMCID: PMC1976702  PMID: 6696821

Abstract

Using a quantitative cytochemical technique for measuring beta-glucuronidase activity in the peripheral nerves of mice, we have investigated the effectiveness of four potential adjuncts for reducing the dose limiting neurotoxicity of misonidazole (MISO) in the clinic. Under the conditions used, the most effective adjunct was the steroid anti-inflammatory agent dexamethasone. When given over the week previous to MISO treatment, this agent almost completely eliminated the MISO neurotoxicity as determined at week 4 after commencement of MISO dosing. The second most effective adjunct was phenytoin, the third flurbiprofen and the last adjunct, phenobarbitone, was ineffective. Dexamethasone, phenytoin and phenobarbitone all reduced the clearance half-life of MISO and hence the drug exposure dose calculated as the area under the curve of MISO tissue concentration against time. However, no correlation was evident with these parameters and MISO neurotoxicity in the mouse. Dexamethasone, whilst affording protection against MISO toxicity, did not alter the radiosensitivity of the anaplastic MT tumour.

Full text

PDF
207

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bleehen N. M. The Cambridge glioma trial of misonidazole and radiation therapy with associated pharmacokinetic studies. Cancer Clin Trials. 1980 Fall;3(3):267–273. [PubMed] [Google Scholar]
  2. Brock W. A., Williams M., McNaney D., Milas L., Peters L. J. The effect of dexamethasone on the radiation sensitivity of cultured cells. Br J Radiol. 1983 Jan;56(661):71–72. doi: 10.1259/0007-1285-56-661-71. [DOI] [PubMed] [Google Scholar]
  3. Brown J. M., Workman P. Partition coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole. Radiat Res. 1980 Apr;82(1):171–190. [PubMed] [Google Scholar]
  4. Clarke C., Dawson K. B., Sheldon P. W., Ahmed I. Neurotoxicity of radiation sensitizers in the mouse. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):787–789. doi: 10.1016/0360-3016(82)90735-0. [DOI] [PubMed] [Google Scholar]
  5. Clarke C., Dawson K. B., Sheldon P. W. Quantitative cytochemical assessment of the neurotoxicity of misonidazole in the mouse. Br J Cancer. 1982 Apr;45(4):582–587. doi: 10.1038/bjc.1982.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dische S., Saunders M. I., Anderson P., Stratford M. R., Minchinton A. Clinical experience with nitroimidazoles as radiosensitizers. Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):335–338. doi: 10.1016/0360-3016(82)90634-4. [DOI] [PubMed] [Google Scholar]
  7. Dische S., Saunders M. I., Flockhart I. R., Lee M. E., Anderson P. Misonidazole-a drug for trial in radiotherapy and oncology. Int J Radiat Oncol Biol Phys. 1979 Jun;5(6):851–860. doi: 10.1016/0360-3016(79)90070-1. [DOI] [PubMed] [Google Scholar]
  8. Dische S., Saunders M. I., Lee M. E., Adams G. E., Flockhart I. R. Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer. 1977 May;35(5):567–579. doi: 10.1038/bjc.1977.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HOLLINGER D. M., ROSSITER R. J. Chemical studies of peripheral nerve during wallerian degeneration. V. B-Glucuronidase. Biochem J. 1952 Dec;52(4):659–663. doi: 10.1042/bj0520659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Marshall W. J., McLean A. E. The effect of oral phenobarbitone on hepatic microsomal cytochrome P-450 and demethylation activity in rats fed normal and low protein diets. Biochem Pharmacol. 1969 Jan;18(1):153–157. doi: 10.1016/0006-2952(69)90020-3. [DOI] [PubMed] [Google Scholar]
  11. Millar B. C., Chaplin D. J., Jinks S. Studies on the protection against misonidazole-induced toxicity by antiinflammatory agents. Adv Prostaglandin Thromboxane Leukot Res. 1983;12:303–308. [PubMed] [Google Scholar]
  12. Millar B. C., Jinks S., Powles T. J. Flurbiprofen, a non-steroid anti-inflammatory agent, protects cells against hypoxic cell radiosensitizers in vitro. Br J Cancer. 1981 Nov;44(5):733–740. doi: 10.1038/bjc.1981.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Millar B. C., Jinks S. The effect of dexamethasone on the radiation survival response and misonidazole-induced hypoxic-cell cytotoxicity in Chinese hamster cells V-79-753B in vitro. Br J Radiol. 1981 Jun;54(642):505–511. doi: 10.1259/0007-1285-54-642-505. [DOI] [PubMed] [Google Scholar]
  14. Sheldon P. W., Batten E. L., Adams G. E. Potentiation of melphalan activity against a murine tumour by nitroimidazole compounds. Br J Cancer. 1982 Oct;46(4):525–531. doi: 10.1038/bjc.1982.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sheldon P. W., Hill S. A. Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice. Br J Cancer. 1977 Jun;35(6):795–808. doi: 10.1038/bjc.1977.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Urtasun R. C., Band P., Chapman J. D., Rabin H. R., Wilson A. F., Fryer C. G. Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative. Radiology. 1977 Mar;122(3):801–804. doi: 10.1148/122.3.801. [DOI] [PubMed] [Google Scholar]
  17. Wasserman T. H., Phillips T. L., Van Raalte G., Urtasun R., Partington J., Koziol D., Schwade J. G., Gangji D., Strong J. M. The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. Br J Radiol. 1980 Feb;53(626):172–173. doi: 10.1259/0007-1285-53-626-172. [DOI] [PubMed] [Google Scholar]
  18. Workman P. Drug interactions with misonidazole: effects of dexamethasone and its derivatives on the pharmacokinetics and toxicity of misonidazole in mice. Biochem Pharmacol. 1980 Oct 15;29(20):2769–2776. doi: 10.1016/0006-2952(80)90010-6. [DOI] [PubMed] [Google Scholar]
  19. Workman P. Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. Br J Cancer. 1979 Sep;40(3):335–353. doi: 10.1038/bjc.1979.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Workman P., Little C. J., Marten T. R., Dale A. D., Ruane R. J., Flockhart I. R., Bleehen N. M. Estimation of the hypoxic cell-sensitiser misonidazole and its O-demethylated metabolite in biological materials by reversed-phase high-performance liquid chromatography. J Chromatogr. 1978 May 1;145(3):507–512. doi: 10.1016/s0378-4347(00)81386-9. [DOI] [PubMed] [Google Scholar]
  21. Workman P. Pharmacokinetics of hypoxic cell radiosensitizers: a review. Cancer Clin Trials. 1980 Fall;3(3):237–251. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES